Cargando…
Tulathromycin and Diclazuril Lack Efficacy against Theileria haneyi, but Tulathromycin Is Not Associated with Adverse Clinical Effects in Six Treated Adult Horses
Equine theileriosis, caused by Theileria haneyi and Theileria equi, leads to anemia, exercise intolerance, and occasionally, death. Theileriosis-free countries prohibit the importation of infected horses, resulting in significant costs for the equine industry. Imidocarb dipropionate is the only trea...
Autores principales: | Onzere, Cynthia K., Hulbert, Morgan, Sears, Kelly P., Williams, Laura B. A., Fry, Lindsay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055745/ https://www.ncbi.nlm.nih.gov/pubmed/36986375 http://dx.doi.org/10.3390/pathogens12030453 |
Ejemplares similares
-
Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi
por: Sears, Kelly, et al.
Publicado: (2020) -
Clinical Progression of Theileria haneyi in Splenectomized Horses Reveals Decreased Virulence Compared to Theileria equi
por: Sears, Kelly P., et al.
Publicado: (2022) -
Development of an Indirect ELISA to Detect Equine Antibodies to Theileria haneyi
por: Bastos, Reginaldo G., et al.
Publicado: (2021) -
Assessment of Draxxin(®) (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi
por: Silva, Marta G., et al.
Publicado: (2018) -
Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia
por: Rutenberg, D., et al.
Publicado: (2017)